Osteoporosis Screening Gaps Among Patients Undergoing Lumbar Fusion Surgery.

J Am Acad Orthop Surg · Oct 23 2026 · Recent

Mao E, Ceballos-Alvarez KE, Thai S, Wang J, Jain A

From the Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD

Spine

SUMMARY — THE REDUCTIONIn a 46,104-patient TriNetX cohort, only 4.5% of men and 15.6% of women had preoperative DEXA before lumbar fusion, and few diagnosed patients received treatment, showing major screening and treatment gaps.
Abstract, as published

BACKGROUND: Osteoporosis is associated with elevated complication rates after lumbar fusion surgery. Despite this, osteoporosis remains both underscreened and undertreated in the United States. Currently, rates of dual-energy radiograph absorptiometry (DEXA) screening before lumbar fusion surgery are unknown, as is the proportion of patients who, after being diagnosed with osteoporosis, receive appropriate treatment. Therefore, the aim of this study was to assess osteoporosis screening and treatment rates among patients undergoing lumbar fusion surgery.

METHODS: Patients older than 50 years undergoing lumbar fusion for lumbar stenosis with degenerative spondylolisthesis were identified using the TriNetX database. Patients receiving surgery for indications of malignancy or infection, as well as those with diagnoses of osteoporosis before the screening window, were excluded. The prevalence of DEXA scans in the 2 years before fusion was calculated for the overall cohort and for high-risk cohorts defined by Endocrinology Society guidelines. A secondary analysis assessed rates of osteoporosis treatment among patients receiving preoperative DEXA scans.

RESULTS: Of 46,104 patients who underwent lumbar fusion surgery, only 4.5% of men and 15.6% of women received a preoperative DEXA scan in the 2 years before their fusion. Women were more likely to receive DEXA scans than men (OR, 3.93; 95% CI, 3.64 to 4.23; P < 0.001). Only 5.6% of high-risk men and 17.5% of high-risk women received preoperative DEXA screening. Among patients diagnosed with osteoporosis after DEXA screening, only 11.0% received anabolic therapy and 23.1% received antiresorptive therapy.

CONCLUSION: Despite most patients undergoing lumbar fusion being at risk of osteoporosis (and eligible for screening), a small minority were screened using DEXA in the 2 years before surgery. Efforts are warranted to increase the prevalence of DEXA screening so that osteoporosis is appropriately diagnosed and treated before lumbar fusion surgery.

Featured in the 2026-10-24 issue.

← Anterior Lumbar Plexus Position on Preoperative Supine MRI Is…Testing criteria for spinal implants: recommendations for the… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.